Although the role of PPARγ in treating diabetic kidney disease was extensively investigated since PPARγ was discovered, the chief mechanism is roughly focused on the inhibition of inflammation and oxidative stress [8] with poorly understood molecular mechanisms. This evidence concerns the gene PPARG and diabetic kidney disease.